Moving Beyond Quality-Adjusted Life-Years in Elderly Care: How Can Multicriteria Decision Analysis Complement Cost-Effectiveness Analysis in Local-Level Decision Making. 2022

Maaike Hoedemakers, and Apostolos Tsiachristas, and Maureen Rutten-van Mölken
Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands. Electronic address: hoedemakers@eshpm.eur.nl.

This study aimed to investigate how multicriteria decision analysis (MCDA) could complement cost-effectiveness analysis (CEA) to support investment decisions in elderly care at local level. We used an integrated elderly care program in The Netherlands as a case study to demonstrate the application of both methods. In a 12-month quasi-experimental study (n = 384), data on the following outcome measures were collected: quality-adjusted life-years (CEA) and physical functioning, psychological well-being, social relationships and participation, enjoyment of life, resilience, person centeredness, continuity of care, and costs (MCDA). We performed regression analysis on inversed probability weighted data and controlled for potential confounders to obtain a double robust estimate of the outcomes. Probabilistic sensitivity analyses determined uncertainty for both methods. The integrated elderly care program was not likely (ie, 36%) to be cost-effective according to the CEA (incremental cost-effectiveness ratios: €88 249 from a societal perspective) using the conventional Dutch willingness-to-pay threshold (ie, €50 000). The MCDA demonstrated that informal caregivers and professionals slightly preferred the intervention over usual care, driven by enjoyment of life and person centeredness. Patients did not prefer either the intervention or usual care, whereas payers and policy makers slightly preferred usual care, mainly due to higher costs of the intervention. MCDA could provide local-level decision makers with a broader measurement of effectiveness by including outcomes beyond health and longevity and the preferences of multiple stakeholders. This additional information could foster the acceptability and implementability of cost-effective innovations in elderly care.

UI MeSH Term Description Entries
D002272 Carcinoembryonic Antigen A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment. Antigens, CD66e,CD66e Antigen,Antigen, CD66e,Antigen, Carcinoembryonic,CD66e Antigens
D003362 Cost-Benefit Analysis A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. In contrast a cost effectiveness in general compares cost with qualitative outcomes. Cost and Benefit,Cost-Benefit Data,Benefits and Costs,Cost Benefit,Cost Benefit Analysis,Cost-Utility Analysis,Costs and Benefits,Economic Evaluation,Marginal Analysis,Analyses, Cost Benefit,Analysis, Cost Benefit,Analysis, Cost-Benefit,Analysis, Cost-Utility,Analysis, Marginal,Benefit and Cost,Cost Benefit Analyses,Cost Benefit Data,Cost Utility Analysis,Cost-Benefit Analyses,Cost-Utility Analyses,Data, Cost-Benefit,Economic Evaluations,Evaluation, Economic,Marginal Analyses
D003661 Decision Support Techniques Mathematical or statistical procedures used as aids in making a decision. They are frequently used in medical decision-making. Decision Analysis,Decision Modeling,Models, Decision Support,Analysis, Decision,Decision Aids,Decision Support Technics,Aid, Decision,Aids, Decision,Analyses, Decision,Decision Aid,Decision Analyses,Decision Support Model,Decision Support Models,Decision Support Technic,Decision Support Technique,Model, Decision Support,Modeling, Decision,Technic, Decision Support,Technics, Decision Support,Technique, Decision Support,Techniques, Decision Support
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D019057 Quality-Adjusted Life Years A measurement index derived from a modification of standard life-table procedures and designed to take account of the quality as well as the duration of survival. This index can be used in assessing the outcome of health care procedures or services. (BIOETHICS Thesaurus, 1994) Adjusted Life Year,Healthy Years Equivalent,QALYs,QUALYs,Quality Adjusted Life Year,Quality-Adjusted Life Year,Adjusted Life Years,Healthy Years Equivalents,Quality Adjusted Life Years,Equivalents, Healthy Years,Life Year, Adjusted,Life Year, Quality-Adjusted,Life Years, Adjusted,Life Years, Quality-Adjusted,QUALY,Years, Adjusted Life
D035501 Uncertainty The condition in which reasonable knowledge regarding risks, benefits, or the future is not available.

Related Publications

Maaike Hoedemakers, and Apostolos Tsiachristas, and Maureen Rutten-van Mölken
January 1997, The Journal of cardiovascular management : the official journal of the American College of Cardiovascular Administrators,
Maaike Hoedemakers, and Apostolos Tsiachristas, and Maureen Rutten-van Mölken
November 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research,
Maaike Hoedemakers, and Apostolos Tsiachristas, and Maureen Rutten-van Mölken
March 2024, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research,
Maaike Hoedemakers, and Apostolos Tsiachristas, and Maureen Rutten-van Mölken
January 2005, Journal of pain & palliative care pharmacotherapy,
Maaike Hoedemakers, and Apostolos Tsiachristas, and Maureen Rutten-van Mölken
May 2006, Allergy,
Maaike Hoedemakers, and Apostolos Tsiachristas, and Maureen Rutten-van Mölken
March 2022, Multiple sclerosis (Houndmills, Basingstoke, England),
Maaike Hoedemakers, and Apostolos Tsiachristas, and Maureen Rutten-van Mölken
April 2013, Clinical therapeutics,
Maaike Hoedemakers, and Apostolos Tsiachristas, and Maureen Rutten-van Mölken
June 2013, JAMA internal medicine,
Maaike Hoedemakers, and Apostolos Tsiachristas, and Maureen Rutten-van Mölken
August 2020, International journal of environmental research and public health,
Maaike Hoedemakers, and Apostolos Tsiachristas, and Maureen Rutten-van Mölken
February 2005, American family physician,
Copied contents to your clipboard!